High flux screening method for screening anaplastic lymphoma kinase inhibitor
A lymphoma kinase and kinase inhibitor technology, applied in the field of pharmacology, can solve the problems of time-consuming, labor-intensive, and difficult to achieve high-throughput screening
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
specific Embodiment approach
[0019] 1. Establishment of screening method for ALK kinase inhibitors
[0020] (1) Experimental materials
[0021] ALK kinase detection kit (Cisbio, France), ALK kinase (Invitrogen, the United States), ATP (Shengxing, China), staurosporine (Beyond, China), 384 low-volume white plate (Coming, the United States), pipette tip ( Axygen, USA).
[0022] (2) Experimental steps
[0023] 1) Carry out ALK kinase concentration gradient, incubation time, substrate concentration, ATP concentration experiments, see Figure 1-4 .
[0024] 2) Accurately weigh the compound to be tested, add DMSO solvent to form a mother solution, and then use the detection buffer to prepare the solution of the compound to be tested to the required concentration. The initial screening concentration is about 1×10 -3 mol / L.
[0025] 3) Add 2 μl of ALK kinase solution, 2 μl of substrate solution, 4 μl of buffer or compound to be screened, and 2 μl of ATP into each well of the reaction vessel. React at room t...
PUM
Property | Measurement | Unit |
---|---|---|
Half inhibitory rate | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com